ARTICLE | Financial News
JHL raises $106M in bond deal
May 30, 2018 4:45 PM UTC
Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were Ruihua Investment, existing investor Milestone Capital and other undisclosed investors.
JHL delisted voluntarily from the Taipei Exchange on Feb. 12 (see BioCentury Extra, Dec. 20, 2017)...
BCIQ Company Profiles